Hematology News

For prevention of venous thromboembolism after noncardiac surgery, direct oral anticoagulants may be preferred over low-molecular-weight heparin, according to a systematic review and meta-analysis.

Patients with venous thromboembolism and obesity had a lower mortality risk than those with normal BMI, according to a study published in Journal of Thrombosis and Haemostasis.

ASH announced the 36 recipients of the society’s 2022 Scholar Awards.

Fox Chase Cancer Center announced two faculty appointments.

Concomitant chemotherapy-induced agranulocytosis and atrial fibrillation was associated with increased in-hospital mortality, hospital stay and health care cost among patients with cancer, a speaker reported.

The FDA approved mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency.

Ambroise Wonkam, MD, PhD, DMedSc, has been appointed director of the department of genetic medicine at Johns Hopkins Medicine.

In patients with cerebral venous thrombosis, direct oral anticoagulants were safer than warfarin without compromising efficacy, researchers reported at the International Stroke Conference.

LentiGlobin led to a reduction in hemolysis and complete resolution of severe vaso-occlusive events among a small cohort of patients with sickle cell disease, according to study results published in The New England Journal of Medicine.

In this video, Allyson Pishko, MD, MSCE, discussed the results of the CADENZA study presented at ASH Annual Meeting and Exposition.